Overview of Dr. Neppalli
Dr. Amarendra Neppalli is an oncologist in Washington, DC and is affiliated with multiple hospitals in the area, including George Washington University Hospital and MUSC Health University Medical Center. He received his medical degree from Osmania Medical College NTR UHS and has been in practice 11 years. He is one of 59 doctors at MUSC Health University Medical Center and one of 38 doctors at George Washington University Hospital who specialize in Oncology. He has 8 publications and over 500 citings.
Office
2150 Pennsylvania Avenue Northwest
Washington, DC 20037
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2015 - 2016
Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015- Louisiana State University School of MedicineResidency, Internal Medicine, 2009 - 2012
Osmania Medical College NTR UHSClass of 2006
Certifications & Licensure
CA State Medical License 2015 - Present
DC State Medical License 2022 - 2026
SC State Medical License 2016 - 2025
LA State Medical License 2012 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 1 citationsEffectiveness, Safety, and Cost Implications of Outpatient Autologous Hematopoietic Stem Cell Transplant for Multiple Myeloma.Jessica Marini, Andy Maldonado, Erin Weeda, Amarendra Neppalli, Hamza Hashmi
Hematology/oncology and Stem Cell Therapy. 2023-05-23 - 34 citationsComparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma.Luciano J. Costa, Yi Lin, R. Frank Cornell, Thomas Martin, Saurabh Chhabra
Clinical Lymphoma, Myeloma & Leukemia. 2021-10-30 - 22 citationsOverall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.Robert F. Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie S. Callander
American Journal of Hematology. 2021-01-01
Abstracts/Posters
- Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...Amarendra K. Neppalli, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...Amarendra K. Neppalli, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
